Literature DB >> 4641856

Rejection of ascites tumor allografts. II. A pathway for cell-mediated tumor destruction in vitro by peritoneal exudate lymphoid cells.

G Berke, K A Sullivan, B Amos.   

Abstract

A pathway for cell-mediated tumor destruction in vitro by immune peritoneal exudate lymphoid cells has been proposed. The union of lymphocytes and tumor cells precedes the formation of an intermediate phase leading to lysis. The initial interaction is only partially temperature dependent. The cytolytic process per se is highly temperature dependent, being negligible at 25 degrees C but proceeding rapidly at 37 degrees C. (51)Cr release from tumor cells is demonstrable within 10 min at 37 degrees C and can be reversibly arrested by cooling. Once initiated, lysis is largely independent of additional interactions and continues at almost full rate for 30 min. The effector cells are not lysed and appear to be free to enter into further effector cycles.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4641856      PMCID: PMC2139331          DOI: 10.1084/jem.136.6.1594

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  THE REACTION OF IMMUNOLOGICALLY ACTIVATED LYMPHOID CELLS AGAINST HOMOLOGOUS LYMPHOID CELLS AGAINST HOMOLOGOUS TARGET TISSUE CELLS IN VITRO.

Authors:  D B WILSON
Journal:  J Cell Comp Physiol       Date:  1963-12

2.  The homograft reaction.

Authors:  P B MEDAWAR
Journal:  Proc R Soc Lond B Biol Sci       Date:  1958-12-04

Review 3.  Cytotoxic effects of lymphoid cells in vitro.

Authors:  P Perlmann; G Holm
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

4.  Fractionation of specific antigen-reactive cells in an in vitro system of cell-mediated immunity.

Authors:  P Lonai; H Wekerle; M Feldman
Journal:  Nat New Biol       Date:  1972-02-23

5.  Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.

Authors:  K T Brunner; J Mauel; J C Cerottini; B Chapuis
Journal:  Immunology       Date:  1968-02       Impact factor: 7.397

6.  Kinetic analysis of a graft reaction induced in cell culture.

Authors:  G Berke; G Yagil; H Ginsburg; M Feldman
Journal:  Immunology       Date:  1969-11       Impact factor: 7.397

7.  Interaction of immune lymphocytes with the mixtures of target cells possessing selected specificities of the H-2 immunizing allele.

Authors:  B D Brondz; A E Snegiröva
Journal:  Immunology       Date:  1971-04       Impact factor: 7.397

8.  Quantitation of the cell-mediated immune response. I. The number of cytolytically active mouse lymphoid cells induced by immunization with allogeneic mastocytoma cells.

Authors:  C S Henney
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

9.  Tumor immunity in vitro: destruction of a mouse ascites tumor through a cycling pathway.

Authors:  G Berke; K A Sullivan; D B Amos
Journal:  Science       Date:  1972-08-04       Impact factor: 47.728

10.  Cellular immunoabsorbents in transplantation immunity. Specific in vitro deletion and recovery of mouse lymphoid cells sensitized against allogeneic tumors.

Authors:  G Berke; R H Levey
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

View more
  9 in total

1.  Viral infection-homograft interactions in a murine model.

Authors:  J D Hamilton; J F Fitzwilliam; K S Cheung; J Shelburne; D J Lang; D B Amos
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

2.  Specificity of cell-mediated transplantation reactions. II. Studies with a sensitive assay of cell-mediated cytotoxicity.

Authors:  P Lake; E Sabbadini; A H Sehon
Journal:  Immunology       Date:  1974-09       Impact factor: 7.397

Review 3.  Lymphotoxin. A review and analysis.

Authors:  W Rosenau; C D Tsoukas
Journal:  Am J Pathol       Date:  1976-09       Impact factor: 4.307

4.  The mechanism of T-cell mediated cytotoxicity. VIII. Zeiosis corresponds to irreversible phase (programming for lysis) in steps leading to lysis.

Authors:  C J Sanderson
Journal:  Immunology       Date:  1981-02       Impact factor: 7.397

5.  Highly lytic CD8+, alpha beta T-cell receptor cytotoxic T cells with major histocompatibility complex (MHC) class I antigen-directed cytotoxicity in beta 2-microglobulin, MHC class I-deficient mice.

Authors:  S Apasov; M Sitkovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

6.  Switch from perforin-expressing to perforin-deficient CD8(+) T cells accounts for two distinct types of effector cytotoxic T lymphocytes in vivo.

Authors:  Avihai Meiraz; Orit Gal Garber; Shaul Harari; David Hassin; Gideon Berke
Journal:  Immunology       Date:  2009-09       Impact factor: 7.397

7.  Exercise delays allogeneic tumor growth and reduces intratumoral inflammation and vascularization.

Authors:  Mark R Zielinski; Melissa Muenchow; Matthew A Wallig; Peggy L Horn; Jeffrey A Woods
Journal:  J Appl Physiol (1985)       Date:  2004-03-12

8.  The differentiation pathway of T lymphocytes. Evidence for two differentiated cell types.

Authors:  A Matter
Journal:  J Exp Med       Date:  1974-08-01       Impact factor: 14.307

9.  Nature of lymphocyte-tumor interaction. A general method for cellular immunoabsorption.

Authors:  R D Stulting; G Berke
Journal:  J Exp Med       Date:  1973-04-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.